Vaccine experiment atrocity: human infection model

It appears that vaccine manufacturers are ever more impatient to reap high profits from new vaccines — especially since they have entered into “public-private” partnerships with governments. Increasingly, government officials oblige this greed-infected industry with laws mandating new vaccines. And public health authorities around the globe have become marketing auxiliaries for vaccine manufacturers.

A report in the Economic Times of India, confirms that the Indian health ministry is working with the Indian Council of Medical Research (ICMR), the Department of Biotechnology, and the Drug Controller General of India (DCGI) as they embark on a medical atrocity – that is, to conduct clinical trials in which human beings are deliberately infected with deadly diseases in order to test the efficacy of experimental vaccines. The India Infection Research Consortium has named these experiments: “controlled human infection model (CHIM)”

This “controlled human infection model” is no different than the medical atrocities committed by the medical establishment under the Nazi regime.

India’s public health officials declare that the CHIM atrocity will abide by “high standards of medical ethics.”

Which standards of medical ethics?

The Nuremberg Code is the most important document in the history of the ethics of medical research.

3. “The experiment should be so designed and based on the results of animal experimentation and a knowledge of the natural history of the disease or other problem under study, that the anticipated results will justify the performance of the experiment.”

VG Somani Dug Controller GeneralVG Somani Dug Controller General

Dr. Gagandeep Kang, Executive Dirctor Translational Health Science & Tech Institute is spearheading the Volunteer Infection Research ConsortiumDr. Gagandeep Kang, Executive Dirctor Translational Health Science & Tech Institute is spearheading the Volunteer Infection Research Consortium

YK Gupta, principal advisor THSTI projectsYK Gupta, principal advisor THSTI projects

Dr. Renu Swarup. Secretary Dept. of BiotechDr. Renu Swarup. Secretary Dept. of Biotech

India will be hosting a gathering  in November to work on broad guidelines for “controlled human infection model” (CHIM) experiments.

The conference will include an international roster of researchers and regulators. The invited regulators include representatives of the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), the U.K. Medicines and Healthcare products Regulatory Agency (MHRA),  and experts from the World Health Organization (WHO). They will be collaborating and lending the veneer of legitimacy to a medical atrocity.

REGISTER NOW
By Vera Sharav

A public advocate for human rights is the founder and president of the Alliance for Human Research Protection (AHRP) which serves as an information resource and public interest watchdog organization whose goal is to unlock the walls of secrecy in biomedical research and bring accountability to that endeavor. AHRP Infomails have a wide following: they are read by physicians and scientists, public health officials, journalists, lawyers, and patient advocacy organizations.

Her advocacy achievements include: suspension of Environmental Protection Agency (EPA) pesticide experiment (CHEERS) on children; complaint led to two federal investigations on the use of children in foster care as guinea pigs in experimental AIDS drug and vaccine trials; suspension of smallpox vaccine on children; suspension of “violence prediction” experiment that exposed 6–11 year old NYC boys of color to fenfluramine ; opened a public debate about the ethics of relapse-inducing experiments in schizophrenia patients. Organized families and victims of unethical research to join her in testifying before the National Bioethics Advisory Committee (NBAC) — re: unethical experimentation on mentally disabled psychiatric patients; those testimonies led to a prize-winning series in the Boston Globe, “Doing Harm: Research on the Mentally Ill” — ultimately resulting in the shutdown of 29 clinical trials at the National Institute of Mental Health (1999).

Mrs. Sharav served on the Children’s Workgroup of the National Human Research Protection Advisory Committee where she was the sole dissenter objecting to expanded use of children in high risk medical experiments. She has testified before public policy advisory panels including, the Institute of Medicine — against human pesticide experiments; against prison drug research; numerous FDA hearings, against misuse of psychotropic drugs for children.

She has been an invited presenter at various professional and academic forums: World Federation of Science Journalists, London; National Academy of Sciences Policy Fellow program and National Public Health Association re: screening for mental illness; Consumers Institute for Medicines and Health, Stockholm — re: America’s overmedicated children; Columbia University; NY Hospital, Cornell; U.S. military medical ethics forum; University of Texas.

Her recent peer-reviewed publications include: Medical Ethics and Contemporary Medicine in Vaccine Epidemic Edited by Louise Kuo Habakus and Mary Holland, JD (2011); Screening for Mental Illness: The Merger of Eugenics and the Drug Industry, Ethical Human Psychology and Psychiatry (2005); Conflicts of Interest in Biomedical Research Harm Children With and Without Disabilities,” Journal of Disability Policy Studies (2004); “The Impact of FDAMA on the recruitment of children for research,” EHPP (2003); “Children in Clinical Research: A Conflict of Moral Values,” American Journal of Bioethics (2003); The ethics of conducting psychosis-inducing experiments,” Accountability in Research (1999).

Read recent Profile of Vera Sharav: “Distrustful of authority…a fierce critic of medical establishment” in STAT News /Reporting from the frontiers of health and medicine.

(Source: ahrp.org; October 16, 2019; https://tinyurl.com/yyg57ajb)
Back to INF

Loading please wait...